Ensemble deep learning: A review

Ensemble learning combines several individual models to obtain better generalization performance. Currently, deep learning models with multilayer processing architecture is showing better performance as compared to the shallow or traditional classification models. Deep ensemble learning models combine the advantages of both the deep learning models as well as the ensemble learning such that the final model has better generalization performance. This paper reviews the state-of-art deep ensemble models and hence serves as an extensive summary for the researchers. The ensemble models are broadly categorised into ensemble models like bagging, boosting and stacking, negative correlation based deep ensemble models, explicit/implicit ensembles, homogeneous /heterogeneous ensemble, decision fusion strategies, unsupervised, semi-supervised, reinforcement learning and online/incremental, multilabel based deep ensemble models. Application of deep ensemble models in different domains is also briefly discussed. Finally, we conclude this paper with some future recommendations and research directions

Modelling and recognition of protein contact networks by multiple kernel learning and dissimilarity representations

Multiple kernel learning is a paradigm which employs a properly constructed chain of kernel functions able to simultaneously analyse different data or different representations of the same data. In this paper, we propose an hybrid classification system based on a linear combination of multiple kernels defined over multiple dissimilarity spaces. The core of the training procedure is the joint optimisation of kernel weights and representatives selection in the dissimilarity spaces. This equips the system with a two-fold knowledge discovery phase: by analysing the weights, it is possible to check which representations are more suitable for solving the classification problem, whereas the pivotal patterns selected as representatives can give further insights on the modelled system, possibly with the help of field-experts. The proposed classification system is tested on real proteomic data in order to predict proteins' functional role starting from their folded structure: specifically, a set of eight representations are drawn from the graph-based protein folded description. The proposed multiple kernel-based system has also been benchmarked against a clustering-based classification system also able to exploit multiple dissimilarities simultaneously. Computational results show remarkable classification capabilities and the knowledge discovery analysis is in line with current biological knowledge, suggesting the reliability of the proposed system

Graph Kernels and Applications in Bioinformatics

In recent years, machine learning has emerged as an important discipline. However, despite the popularity of machine learning techniques, data in the form of discrete structures are not fully exploited. For example, when data appear as graphs, the common choice is the transformation of such structures into feature vectors. This procedure, though convenient, does not always effectively capture topological relationships inherent to the data; therefore, the power of the learning process may be insufficient. In this context, the use of kernel functions for graphs arises as an attractive way to deal with such structured objects. On the other hand, several entities in computational biology applications, such as gene products or proteins, may be naturally represented by graphs. Hence, the demanding need for algorithms that can deal with structured data poses the question of whether the use of kernels for graphs can outperform existing methods to solve specific computational biology problems. In this dissertation, we address the challenges involved in solving two specific problems in computational biology, in which the data are represented by graphs. First, we propose a novel approach for protein function prediction by modeling proteins as graphs. For each of the vertices in a protein graph, we propose the calculation of evolutionary profiles, which are derived from multiple sequence alignments from the amino acid residues within each vertex. We then use a shortest path graph kernel in conjunction with a support vector machine to predict protein function. We evaluate our approach under two instances of protein function prediction, namely, the discrimination of proteins as enzymes, and the recognition of DNA binding proteins. In both cases, our proposed approach achieves better prediction performance than existing methods. Second, we propose two novel semantic similarity measures for proteins based on the gene ontology. The first measure directly works on the gene ontology by combining the pairwise semantic similarity scores between sets of annotating terms for a pair of input proteins. The second measure estimates protein semantic similarity using a shortest path graph kernel to take advantage of the rich semantic knowledge contained within ontologies. Our comparison with other methods shows that our proposed semantic similarity measures are highly competitive and the latter one outperforms state-of-the-art methods. Furthermore, our two methods are intrinsic to the gene ontology, in the sense that they do not rely on external sources to calculate similarities

Biomarker lists stability in genomic studies: analysis and improvement by prior biological knowledge integration into the learning process

The analysis of high-throughput sequencing, microarray and mass spectrometry data has been demonstrated extremely helpful for the identification of those genes and proteins, called biomarkers, helpful for answering to both diagnostic/prognostic and functional questions. In this context, robustness of the results is critical both to understand the biological mechanisms underlying diseases and to gain sufficient reliability for clinical/pharmaceutical applications. Recently, different studies have proved that the lists of identified biomarkers are poorly reproducible, making the validation of biomarkers as robust predictors of a disease a still open issue. The reasons of these differences are referable to both data dimensions (few subjects with respect to the number of features) and heterogeneity of complex diseases, characterized by alterations of multiple regulatory pathways and of the interplay between different genes and the environment. Typically in an experimental design, data to analyze come from different subjects and different phenotypes (e.g. normal and pathological). The most widely used methodologies for the identification of significant genes related to a disease from microarray data are based on computing differential gene expression between different phenotypes by univariate statistical tests. Such approach provides information on the effect of specific genes as independent features, whereas it is now recognized that the interplay among weakly up/down regulated genes, although not significantly differentially expressed, might be extremely important to characterize a disease status. Machine learning algorithms are, in principle, able to identify multivariate nonlinear combinations of features and have thus the possibility to select a more complete set of experimentally relevant features. In this context, supervised classification methods are often used to select biomarkers, and different methods, like discriminant analysis, random forests and support vector machines among others, have been used, especially in cancer studies. Although high accuracy is often achieved in classification approaches, the reproducibility of biomarker lists still remains an open issue, since many possible sets of biological features (i.e. genes or proteins) can be considered equally relevant in terms of prediction, thus it is in principle possible to have a lack of stability even by achieving the best accuracy. This thesis represents a study of several computational aspects related to biomarker discovery in genomic studies: from the classification and feature selection strategies to the type and the reliability of the biological information used, proposing new approaches able to cope with the problem of the reproducibility of biomarker lists. The study has highlighted that, although reasonable and comparable classification accuracy can be achieved by different methods, further developments are necessary to achieve robust biomarker lists stability, because of the high number of features and the high correlation among them. In particular, this thesis proposes two different approaches to improve biomarker lists stability by using prior information related to biological interplay and functional correlation among the analyzed features. Both approaches were able to improve biomarker selection. The first approach, using prior information to divide the application of the method into different subproblems, improves results interpretability and offers an alternative way to assess lists reproducibility. The second, integrating prior information in the kernel function of the learning algorithm, improves lists stability. Finally, the interpretability of results is strongly affected by the quality of the biological information available and the analysis of the heterogeneities performed in the Gene Ontology database has revealed the importance of providing new methods able to verify the reliability of the biological properties which are assigned to a specific feature, discriminating missing or less specific information from possible inconsistencies among the annotations. These aspects will be more and more deepened in the future, as the new sequencing technologies will monitor an increasing number of features and the number of functional annotations from genomic databases will considerably grow in the next years.L’analisi di dati high-throughput basata sull’utilizzo di tecnologie di sequencing, microarray e spettrometria di massa si è dimostrata estremamente utile per l’identificazione di quei geni e proteine, chiamati biomarcatori, utili per rispondere a quesiti sia di tipo diagnostico/prognostico che funzionale. In tale contesto, la stabilità dei risultati è cruciale sia per capire i meccanismi biologici che caratterizzano le malattie sia per ottenere una sufficiente affidabilità per applicazioni in campo clinico/farmaceutico. Recentemente, diversi studi hanno dimostrato che le liste di biomarcatori identificati sono scarsamente riproducibili, rendendo la validazione di tali biomarcatori come indicatori stabili di una malattia un problema ancora aperto. Le ragioni di queste differenze sono imputabili sia alla dimensione dei dataset (pochi soggetti rispetto al numero di variabili) sia all’eterogeneità di malattie complesse, caratterizzate da alterazioni di più pathway di regolazione e delle interazioni tra diversi geni e l’ambiente. Tipicamente in un disegno sperimentale, i dati da analizzare provengono da diversi soggetti e diversi fenotipi (e.g. normali e patologici). Le metodologie maggiormente utilizzate per l’identificazione di geni legati ad una malattia si basano sull’analisi differenziale dell’espressione genica tra i diversi fenotipi usando test statistici univariati. Tale approccio fornisce le informazioni sull’effetto di specifici geni considerati come variabili indipendenti tra loro, mentre è ormai noto che l’interazione tra geni debolmente up/down regolati, sebbene non differenzialmente espressi, potrebbe rivelarsi estremamente importante per caratterizzare lo stato di una malattia. Gli algoritmi di machine learning sono, in linea di principio, capaci di identificare combinazioni non lineari delle variabili e hanno quindi la possibilità di selezionare un insieme più dettagliato di geni che sono sperimentalmente rilevanti. In tale contesto, i metodi di classificazione supervisionata vengono spesso utilizzati per selezionare i biomarcatori, e diversi approcci, quali discriminant analysis, random forests e support vector machines tra altri, sono stati utilizzati, soprattutto in studi oncologici. Sebbene con tali approcci di classificazione si ottenga un alto livello di accuratezza di predizione, la riproducibilità delle liste di biomarcatori rimane ancora una questione aperta, dato che esistono molteplici set di variabili biologiche (i.e. geni o proteine) che possono essere considerati ugualmente rilevanti in termini di predizione. Quindi in teoria è possibile avere un’insufficiente stabilità anche raggiungendo il massimo livello di accuratezza. Questa tesi rappresenta uno studio su diversi aspetti computazionali legati all’identificazione di biomarcatori in genomica: dalle strategie di classificazione e di feature selection adottate alla tipologia e affidabilità dell’informazione biologica utilizzata, proponendo nuovi approcci in grado di affrontare il problema della riproducibilità delle liste di biomarcatori. Tale studio ha evidenziato che sebbene un’accettabile e comparabile accuratezza nella predizione può essere ottenuta attraverso diversi metodi, ulteriori sviluppi sono necessari per raggiungere una robusta stabilità nelle liste di biomarcatori, a causa dell’alto numero di variabili e dell’alto livello di correlazione tra loro. In particolare, questa tesi propone due diversi approcci per migliorare la stabilità delle liste di biomarcatori usando l’informazione a priori legata alle interazioni biologiche e alla correlazione funzionale tra le features analizzate. Entrambi gli approcci sono stati in grado di migliorare la selezione di biomarcatori. Il primo approccio, usando l’informazione a priori per dividere l’applicazione del metodo in diversi sottoproblemi, migliora l’interpretabilità dei risultati e offre un modo alternativo per verificare la riproducibilità delle liste. Il secondo, integrando l’informazione a priori in una funzione kernel dell’algoritmo di learning, migliora la stabilità delle liste. Infine, l’interpretabilità dei risultati è fortemente influenzata dalla qualità dell’informazione biologica disponibile e l’analisi delle eterogeneità delle annotazioni effettuata sul database Gene Ontology rivela l’importanza di fornire nuovi metodi in grado di verificare l’attendibilità delle proprietà biologiche che vengono assegnate ad una specifica variabile, distinguendo la mancanza o la minore specificità di informazione da possibili inconsistenze tra le annotazioni. Questi aspetti verranno sempre più approfonditi in futuro, dato che le nuove tecnologie di sequencing monitoreranno un maggior numero di variabili e il numero di annotazioni funzionali derivanti dai database genomici crescer`a considerevolmente nei prossimi anni

Deciphering the functional organization of molecular networks via graphlets-based methods and network embedding techniques

[eng] Advances in capturing technologies have yielded a massive production of large-scale molecular data that describe different aspects of cellular functioning. These data are often modeled as networks, in which nodes are molecular entities, and the edges connecting them represent their relationships. These networks are a valuable source of biological information, but they need to be untangled by new algorithms to reveal the information hidden in their wiring patterns. State-of-the-art approaches for deciphering these complex networks are based on graphlets and network embeddings. This thesis focuses on the development of novel algorithms to overcome the limitations of the current graphlet and network embedding methodologies in the field of biology. Graphlets are a powerful tool for characterizing the local wiring patterns of molecular networks. However, current graphlet-based methods are mostly applicable to unweighted networks, whereas real-world molecular networks may have weighted edges that represent the probability of an interaction occurring in the cell. This probabilistic information is commonly discarded when applying thresholds to generate unweighted networks, which may lead to information loss. To address this challenge, we introduce probabilistic graphlets, a novel approach that can capture the local wiring patterns of weighted networks and uncover hidden probabilistic relationships between molecular entities. We use probabilistic graphlets to generalize the graphlet methods and apply these to the probabilistic representation of real-world molecular interactions. We show that probabilistic graphlets robustly un- cover relevant biological information from the molecular networks. Furthermore, we demonstrate that probabilistic graphlets exhibit a higher sensitivity to identifying condition-specific functions compared to their unweighted counterparts. Network embedding algorithms learn a low-dimensional vectorial representation for each gene in the network while preserving the structural information of the molecular network. Current, available embedding approaches strictly focus on clustering the genes’ embedding vectors and interpreting such clusters to reveal the hidden information of the biological networks. Thus, we investigate new perspectives and methods that go beyond gene-centric approaches. First, we shift the exploration of the embedding space’s functional organization from the genes to their functions. We introduce the Functional Mapping Matrix and apply it to investigate the changes in the organization of cancer and control network embedding spaces from a functional perspective. We demonstrate that our methodology identifies novel cancer-related functions and genes that the currently available methods for gene-centric analyses cannot identify. Finally, we go even further and switch the perspective from the organization of the embedded entities (genes and functions) in the embedding space to the space itself. We annotate axes of the network embedding spaces of six species with both, functional annotations and genes. We demonstrate that the embedding space axes represent coherent cellular functions and offer a functional fingerprint of the cell’s functional organization. Moreover, we show that the analysis of the axes reveals new functional evolutionary connections between species